Back to search
FDAFDA · Food and drugs·Recall number D-0261-2024

Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18

Published January 31, 2024 · Recall initiated: December 21, 2023

Summary

FDA records drug Class I recall D-0261-2024, published January 31, 2024 and initiated December 21, 2023. Recalling firm: PFIZER; Status: Ongoing; Reported quantity: 3,546 vials; Lot: Lot #: BL12206A, Exp date 06/30/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of particulate matter: glass

What to do

Voluntary: Firm initiated · Press Release

Get an email if BLEOMYCIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BLEOMYCIN
Manufacturer
PFIZER
Distributor
Nationwide in the USA, Netherlands and Libya
Lot
Lot #: BL12206A, Exp date 06/30/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18 recalled?

Yes. FDA published recall D-0261-2024 on January 31, 2024. Reported hazard: Presence of particulate matter: glass

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BLEOMYCIN.